At a glance
- Originator Aventis
- Class Anti-ischaemics; Antiarrhythmics; Guanidines; Small molecules; Sulfones
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Myocardial infarction